{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T12:17:34Z","timestamp":1648815454414},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s00120-013-3308-0","type":"journal-article","created":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T12:18:53Z","timestamp":1378901933000},"page":"1251-1255","source":"Crossref","is-referenced-by-count":0,"title":["Proteombasierte diagnostische und prognostische Biomarker beim Prostatakarzinom"],"prefix":"10.1007","volume":"52","author":[{"given":"J.","family":"Neuhaus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Siwy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Mannello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.-C.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-U.","family":"Stolzenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,13]]},"reference":[{"key":"3308_CR1","first-page":"77","volume":"8","author":"Conrads","year":"2004","unstructured":"Conrads TP, Hood BL, Issaq HJ, Veenstra TD (2004) Proteomic patterns as a diagnostic tool for early-stage cancer: a review of its progress to a clinically relevant tool. Mol Diagn 8:77\u201385","journal-title":"Mol Diagn"},{"key":"3308_CR2","unstructured":"DGU (2009) Interdisziplin\u00e4re Leitlinie der Qualit\u00e4t S3 zur Fr\u00fcherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms. DGU, Berlin"},{"key":"3308_CR3","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jprot.2009.01.007","volume":"72","author":"Drake","year":"2009","unstructured":"Drake RR, White KY, Fuller TW et al (2009) Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease. J Proteomics 72:907\u2013917","journal-title":"J Proteomics"},{"key":"3308_CR4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.ju.0000141781.70474.48","volume":"172","author":"Gelmann","year":"2004","unstructured":"Gelmann EP, Semmes OJ (2004) Expression of genes and proteins specific for prostate cancer. J Urol 172:23\u201327","journal-title":"J Urol"},{"key":"3308_CR5","first-page":"CD004720","volume":"1","author":"Ilic","year":"2013","unstructured":"Ilic D, Neuberger MM, Djulbegovic M, Dahm P (2013) Screening for prostate cancer. Cochrane Database Syst Rev 1:CD004720","journal-title":"Cochrane Database Syst Rev"},{"key":"3308_CR6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69\u201390","journal-title":"CA Cancer J Clin"},{"key":"3308_CR7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"Jemal","year":"2009","unstructured":"Jemal A, Siegel R, Ward E et al (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225\u2013249","journal-title":"CA Cancer J Clin"},{"key":"3308_CR8","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1074\/mcp.M112.017889","volume":"11","author":"Kim","year":"2012","unstructured":"Kim Y, Ignatchenko V, Yao CQ et al (2012) Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer. Mol Cell Proteomics 11:1870\u20131884","journal-title":"Mol Cell Proteomics"},{"key":"3308_CR9","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/mas.20051","volume":"24","author":"Kolch","year":"2005","unstructured":"Kolch W, Neususs C, Pelzing M, Mischak H (2005) Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrom Rev 24:959\u2013977","journal-title":"Mass Spectrom Rev"},{"key":"3308_CR10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/prca.200780159","volume":"2","author":"Li","year":"2008","unstructured":"Li R, Guo Y, Han BM et al (2008) Proteomics cataloging analysis of human expressed prostatic secretions reveals rich source of biomarker candidates. Proteomics Clin Appl 2:543\u2013555","journal-title":"Proteomics Clin Appl"},{"key":"3308_CR11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/1568009054064615","volume":"5","author":"Mannello","year":"2005","unstructured":"Mannello F, Tonti G, Papa S (2005) Matrix metalloproteinase inhibitors as anticancer therapeutics. Curr Cancer Drug Targets 5:285\u2013298","journal-title":"Curr Cancer Drug Targets"},{"key":"3308_CR12","doi-asserted-by":"crossref","first-page":"67514","DOI":"10.1371\/journal.pone.0067514","volume":"8","author":"Neuhaus","year":"2013","unstructured":"Neuhaus J, Schiffer E, Philine W von et al (2013) Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease. PLoS One 8:67514","journal-title":"PLoS One"},{"key":"3308_CR13","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1097\/01.ju.0000139572.88463.39","volume":"172","author":"Ornstein","year":"2004","unstructured":"Ornstein DK, Rayford W, Fusaro VA et al (2004) Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0\u00a0ng\/ml. J Urol 172:1302\u20131305","journal-title":"J Urol"},{"key":"3308_CR14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0033-8389(05)70149-4","volume":"38","author":"Presti","year":"2000","unstructured":"Presti JCJ (2000) Prostate cancer: assessment of risk using digital rectal examination, tumor grade, prostate-specific antigen, and systematic biopsy. Radiol Clin North Am 38:49\u201358","journal-title":"Radiol Clin North Am"},{"key":"3308_CR15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00345-007-0203-6","volume":"25","author":"Schiffer","year":"2007","unstructured":"Schiffer E (2007) Biomarkers for prostate cancer. World J Urol 25:557\u2013562","journal-title":"World J Urol"},{"key":"3308_CR16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1442-2042.2011.02901.x","volume":"19","author":"Schiffer","year":"2012","unstructured":"Schiffer E, Bick C, Grizelj B et al (2012) Urinary proteome analysis for prostate cancer diagnosis: cost-effective application in routine clinical practice in Germany. Int J Urol 19:118\u2013125","journal-title":"Int J Urol"},{"key":"3308_CR17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1464-410X.2007.07283.x","volume":"101","author":"Shariat","year":"2008","unstructured":"Shariat SF, Karam JA, Margulis V, Karakiewicz PI (2008) New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer. BJU Int 101:675\u2013683","journal-title":"BJU Int"},{"key":"3308_CR18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/prca.200780082","volume":"2","author":"Theodorescu","year":"2008","unstructured":"Theodorescu D, Schiffer E, Bauer HW et al (2008) Discovery and validation of urinary biomarkers for prostate cancer. Proteomics Clin Appl 2:556\u2013570","journal-title":"Proteomics Clin Appl"},{"key":"3308_CR19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1470-2045(06)70584-8","volume":"7","author":"Theodorescu","year":"2006","unstructured":"Theodorescu D, Wittke S, Ross MM et al (2006) Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol 7:230\u2013240","journal-title":"Lancet Oncol"},{"key":"3308_CR20","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","volume":"350","author":"Thompson","year":"2004","unstructured":"Thompson IM, Pauler DK, Goodman PJ et al (2004) Prevalence of prostate cancer among men with a prostate-specific antigen level < or =\u20094.0\u00a0ng per milliliter. N Engl J Med 350:2239\u20132246","journal-title":"N Engl J Med"},{"key":"3308_CR21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/pr800615t","volume":"8","author":"Zur","year":"2009","unstructured":"Zur Muhlen C von, Schiffer E, Zuerbig P et al (2009) Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients. J Proteome Res 8:335\u2013345","journal-title":"J Proteome Res"},{"key":"3308_CR22","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJMoa051931","volume":"353","author":"Wang","year":"2005","unstructured":"Wang X, Yu J, Sreekumar A et al (2005) Autoantibody signatures in prostate cancer. N Engl J Med 353:1224\u20131235","journal-title":"N Engl J Med"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-013-3308-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-013-3308-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-013-3308-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:04:25Z","timestamp":1558609465000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-013-3308-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["3308"],"URL":"https:\/\/doi.org\/10.1007\/s00120-013-3308-0","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}